hememalignancy.mc.duke.edu  
   
School of Medicine » Department of Medicine » Division of Cell Therapy
Our multidisciplinary Hematologic Malignancy Program focuses on the care of patients with lymphoma, leukemia, myeloma, myelodysplasias, myeloproliferative disorders, aplasia, or other neoplastic diseases of the marrow or blood system. More »
Staff Only
For study files, go to Cellular Therapy Clinical Trials.
 
Announcements
Dr. Joseph Moore remains a national leader in the diagnosis and treatment of oncologic problems and has again been named to the lists of 'Best Doctor's in America'  and 'America's Top Doctors for Cancer' by Castle Connolly Medical ltd.
 
Dr. Rizzieri received a 'Scholar in Clinical Research' grant from the Leukemia and Lymphoma society!
visit www.lls.org for more information on the society and this prestigious grant.
 
 
Save the Date!
Duke Debates - Controversies in the Management of Patients with Hematologic Malignancies
Thanks to all those who made this March 08 event a resounding success.
 
6th annual event planning is underway!
contact Mrs. Monica Roberson at
919 419 5506 for information
More »
 
 
Patient Perspectives
Ann Vannostrand:
“When I was told I had cancer and the medicine my doctor tried didn't work, I was offered some choices of where to be treated. I knew there was one place I wanted to go - Duke!.”  More Patient Stories »
Disclaimer      Duke & Your Privacy      © 2008, Duke University Health System  
DHTS Strategic Web Services DHTS STRATEGIC WEB SERVICES